ED Coding & Reimbursement Alert - 2005 Issue 27
MEDICARE DRUG BENEFIT: Still Plenty Of Room For Efficient PDPs To Profit
Subscribe or sign in to view the full article.
Article Overview
This article examines how new Centers for Medicare and Medicaid Services guidance on the Medicare Part D drug benefit may affect potential prescription drug plan sponsors. It focuses on plan management tools such as step therapy and tiered formularies, and it is relevant to Medicare policy readers, pharmacy benefit professionals, and plan sponsors evaluating benefit design and profitability.
Why This Topic Matters
It helps readers understand the practical implications of CMS guidance for Part D plan operations and the general strategies sponsors may use to manage drug spending and benefit structure.
What You Will Learn
- How the article frames CMS guidance on Medicare Part D
- What plan design tools are discussed in the context of PDP operations
- Why step therapy is presented as an important strategy for plan sponsors
- How pharmacy benefit management concepts are connected to Part D profitability
Who Should Read This
- Medicare Part D plan sponsors
- Pharmacy benefit managers
- Health policy professionals
- Coding and reimbursement researchers
- Managed care and benefits administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com